Department of Orthopaedic Surgery, The 1st Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Spine Surgery Center, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Neurosurgery. 2019 Aug 1;85(2):211-222. doi: 10.1093/neuros/nyy237.
Single-stage spine-shortening osteotomy without treating spinal cord malformations may have potential advantages for the treatment of severe congenital scoliosis (CS) with type I split spinal cord malformation (SSCM); however, the study of this technique was limited.
To evaluate the safety and efficacy of a single-stage spine-shortening osteotomy in the treatment of severe CS associated with type I SSCM.
A retrospective study was designed to compare 2 case series including 12 severe CS patients with type I SSCM and 26 patients with type A cord function (without spinal cord malformations, evoked potential abnormalities, and neurological dysfunctions preoperatively) treated with a single-stage spine-shortening posterior vertebral column resection (PVCR). Patient demographic, clinical, operative, and radiographic data were obtained and compared between groups.
The surgical procedure was successfully performed in both groups, and the patients were observed for an average of 44.9 mo (range 25-78 mo) after the initial surgery. The radiographic parameters, intraoperative data, and new neurological deficits showed no difference, while deformity angular ratio (SSCM group: control group = 16.6 ± 3.6: 20.1 ± 3.9, P = .01) and corrective rate (SSCM group: control group = 50%: 58%, P = .046) of the main curve were statistically different between groups. All of the new neurological deficits were recovered within 1 yr.
The single-stage spine-shortening PVCR with moderate correction could be applied to the treatment of CS associated with type I SSCM. This strategy can achieve safe spinal deformity correction while obviate the neurological complications brought by the detethering procedures, which merits further clinical investigation.
对于伴有 I 型脊髓纵裂(SSCM)的严重先天性脊柱侧凸(CS),一期脊柱缩短截骨术而不治疗脊髓畸形可能具有潜在优势;然而,该技术的研究有限。
评估一期脊柱缩短截骨术治疗伴有 I 型 SSCM 的严重 CS 的安全性和疗效。
设计了一项回顾性研究,比较了 2 个病例系列,共纳入 12 例伴有 I 型 SSCM 的严重 CS 患者和 26 例伴有 A 型脊髓功能(术前无脊髓畸形、诱发电位异常和神经功能障碍)的患者,均接受一期脊柱缩短后路椎体切除术(PVCR)治疗。比较两组患者的人口统计学、临床、手术和影像学资料。
两组患者的手术均顺利完成,术后平均随访 44.9 个月(25-78 个月)。影像学参数、术中数据和新的神经功能缺损无差异,而主弯畸形角比值(SSCM 组:对照组=16.6±3.6:20.1±3.9,P=0.01)和矫正率(SSCM 组:对照组=50%:58%,P=0.046)存在统计学差异。所有新的神经功能缺损均在 1 年内恢复。
一期适度矫正的脊柱缩短 PVCR 可用于治疗伴有 I 型 SSCM 的 CS。该策略可以安全地矫正脊柱畸形,同时避免松解术带来的神经并发症,值得进一步的临床研究。